Skip to main content
Journal cover image

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.

Publication ,  Journal Article
Shah, NN; Schneiderman, J; Kuruvilla, D; Bhojwani, D; Fry, TJ; Martin, PL; Schultz, KR; Silverman, LB; Whitlock, JA; Wood, B; Vainshtein, I ...
Published in: Pediatr Blood Cancer
January 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Blood Cancer

DOI

EISSN

1545-5017

Publication Date

January 2021

Volume

68

Issue

1

Start / End Page

e28574

Location

United States

Related Subject Headings

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Oncology & Carcinogenesis
  • Neoplasm, Residual
  • Immunotoxins
  • Humans
  • Female
  • Fatal Outcome
  • Exotoxins
  • Child
  • Capillary Leak Syndrome
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shah, N. N., Schneiderman, J., Kuruvilla, D., Bhojwani, D., Fry, T. J., Martin, P. L., … Wayne, A. S. (2021). Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer, 68(1), e28574. https://doi.org/10.1002/pbc.28574
Shah, Nirali N., Jennifer Schneiderman, Denison Kuruvilla, Deepa Bhojwani, Terry J. Fry, Paul L. Martin, Kirk R. Schultz, et al. “Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.Pediatr Blood Cancer 68, no. 1 (January 2021): e28574. https://doi.org/10.1002/pbc.28574.
Shah NN, Schneiderman J, Kuruvilla D, Bhojwani D, Fry TJ, Martin PL, et al. Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer. 2021 Jan;68(1):e28574.
Shah, Nirali N., et al. “Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.Pediatr Blood Cancer, vol. 68, no. 1, Jan. 2021, p. e28574. Pubmed, doi:10.1002/pbc.28574.
Shah NN, Schneiderman J, Kuruvilla D, Bhojwani D, Fry TJ, Martin PL, Schultz KR, Silverman LB, Whitlock JA, Wood B, Vainshtein I, Adams A, Confer D, Pulsipher MA, Chaudhury S, Wayne AS. Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer. 2021 Jan;68(1):e28574.
Journal cover image

Published In

Pediatr Blood Cancer

DOI

EISSN

1545-5017

Publication Date

January 2021

Volume

68

Issue

1

Start / End Page

e28574

Location

United States

Related Subject Headings

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Oncology & Carcinogenesis
  • Neoplasm, Residual
  • Immunotoxins
  • Humans
  • Female
  • Fatal Outcome
  • Exotoxins
  • Child
  • Capillary Leak Syndrome